Cord blood trial aims to boost platelets in cancer patients
NCT ID NCT07441720
Summary
This study is testing if an infusion of umbilical cord blood can safely help cancer patients whose platelet counts have dropped dangerously low due to their cancer treatments. The trial will enroll 25 patients aged 12-65 to receive the cord blood infusion and then track their platelet recovery and any side effects for a month. The goal is to see if this approach can help control this serious side effect and reduce the need for platelet transfusions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Hematology, Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.